209 related articles for article (PubMed ID: 2828337)
1. Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.
Sioud M; Possot O; Elie C; Sibold L; Forterre P
J Bacteriol; 1988 Feb; 170(2):946-53. PubMed ID: 2828337
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin and etoposide (VP16) produce a similar pattern of DNA cleavage in a plasmid of an archaebacterium.
Sioud M; Forterre P
Biochemistry; 1989 May; 28(9):3638-41. PubMed ID: 2751986
[TBL] [Abstract][Full Text] [Related]
3. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
4. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
Kranz RG; Beckman DL; Foster-Hartnett D
FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
[TBL] [Abstract][Full Text] [Related]
5. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
6. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
Samuels DS; Garon CF
Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
[TBL] [Abstract][Full Text] [Related]
7. Novobiocin induces positive supercoiling of small plasmids from halophilic archaebacteria in vivo.
Sioud M; Baldacci G; de Recondo AM; Forterre P
Nucleic Acids Res; 1988 Feb; 16(4):1379-91. PubMed ID: 3347494
[TBL] [Abstract][Full Text] [Related]
8. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert M; O'Dea MH; Itoh T; Tomizawa J
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4474-8. PubMed ID: 794878
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
10. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
11. Mutations in DNA gyrase result in novobiocin resistance in halophilic archaebacteria.
Holmes ML; Dyall-Smith ML
J Bacteriol; 1991 Jan; 173(2):642-8. PubMed ID: 1846146
[TBL] [Abstract][Full Text] [Related]
12. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
[TBL] [Abstract][Full Text] [Related]
13. 4-Quinolone interactions with gyrase subunit B inhibitors.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
[TBL] [Abstract][Full Text] [Related]
14. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
[TBL] [Abstract][Full Text] [Related]
15. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex.
Babinchak TJ; Fass RJ
Diagn Microbiol Infect Dis; 1992; 15(4):367-70. PubMed ID: 1319302
[TBL] [Abstract][Full Text] [Related]
17. A plasmid vector with a selectable marker for halophilic archaebacteria.
Holmes ML; Dyall-Smith ML
J Bacteriol; 1990 Feb; 172(2):756-61. PubMed ID: 2105303
[TBL] [Abstract][Full Text] [Related]
18. Positively supercoiled plasmid DNA is produced by treatment of Escherichia coli with DNA gyrase inhibitors.
Lockshon D; Morris DR
Nucleic Acids Res; 1983 May; 11(10):2999-3017. PubMed ID: 6304617
[TBL] [Abstract][Full Text] [Related]
19. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
Schmutz E; Mühlenweg A; Li SM; Heide L
Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
[TBL] [Abstract][Full Text] [Related]
20. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
Howard BM; Pinney RJ; Smith JT
Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
